45 results on '"Lam, John S."'
Search Results
2. In Vivo Efficacy of Laparoscopic Assisted Percutaneous Renal Cryotherapy: Evidence Based Guidelines for the Practicing Urologist
3. Platelet Count and Preoperative Haemoglobin Do Not Significantly Increase the Performance of Established Predictors of Renal Cell Carcinoma-Specific Mortality
4. Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 Cases
5. Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience
6. Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication
7. Prognostic Impact of Tumor Size on pT2 Renal Cell Carcinoma: An International Multicenter Experience
8. Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval
9. Ureteropelvic Junction Obstruction
10. RENCA/carbonic anhydrase-IX: A murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma
11. Role of molecular markers in the diagnosis and therapy of renal cell carcinoma
12. POSTOPERATIVE SURVEILLANCE PROTOCOL FOR PATIENTS WITH LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA BASED ON A VALIDATED PROGNOSTIC NOMOGRAM AND RISK GROUP STRATIFICATION SYSTEM
13. Changing Concepts in the Surgical Management of Renal Cell Carcinoma
14. Update on ureteral stents
15. Changing aspects in the evaluation and treatment of patients with benign prostatic hyperplasia
16. SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE
17. EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS PREDICTS BONE METASTASIS IN PATIENTS PRESENTING WITH RENAL CELL CARCINOMA: IMPLICATION FOR PREOPERATIVE BONE SCANS
18. Bacillus calmete-guérin plus interferon-α2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity
19. Comparison of the Predictive Accuracy of Serum Prostate Specific Antigen Levels and Prostate Specific Antigen Density in the Detection of Prostate Cancer in Hispanic-American and White Men
20. Is Hispanic Race an Independent Risk Factor for Pathological Stage in Patients Undergoing Radical Prostatectomy?
21. PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study
22. Treatment of Proximal Ureteral Calculi: Holmium:Yag Laser Ureterolithotripsy Versus Extracorporeal Shock Wave Lithotripsy
23. RETRACTED: Stem cells in prostate and prostate cancer development
24. Organ-confined primitive neuroectodermal tumor arising from the kidney
25. NEPHRON-SPARING SURGERY VS. RADICAL NEPHRECTOMY IN PATIENTS WITH RENAL CELL CARCINOMA >7 CM. WITH NO EVIDENCE OF NODAL OR DISTANT METASTATSIS
26. PREDICTIVE FACTORS FOR LOCAL RECURRENCE AFTER NEPHRON SPARING SURGERY IN RENAL CELL CARCINOMA
27. PARTIAL NEPHRECTOMY FOR RENAL MASSES: CAN WE APPLY THE QUALITY OF CARE CONCERN ADDRESSED BY THE UROLOGICAL COMMUNITY, TO THE EUROPEAN POPULATION?
28. 1291: Prognostic Impact of Cytogenetic Findings in Clear Cell Renal Cell Carcinoma: Improved Survival is Seen in Patients with Loss of Chromosome 3P
29. 1255: Potential Role of Postoperative Azotemia in Predicting Response to Interleukin-2 (IL-2) Immunotherapy Following Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
30. 1246: Nephron-Sparing Surgery does not Undermine Renal Cell Carcinoma-Specific Survival in Patients with PT3 Renal Cell Carcinoma
31. 1118: Impact of Histology on Cancer Control after Nephron Sparing Surgery for Renal Cell Carcinoma
32. 1117: The Malignant Potential and Prognosis of Small Renal Tumors
33. 915: Prognosis and Survival of Synchronous Bilateral Renal Cell Carcinoma: A Multicenter Experience
34. 900: Loss of 3P, Loss of 9P and Trisomy 17 Predict Prognosis in Patients with Papillary Renal Cell Carcinoma
35. 646: Morbidity of Nephron Sparing Surgery for Hilar Tumors
36. 491: Molecular Tumor Profiling Improves Risk Assessment and Prognostication of Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma
37. 79: Trends in the Management and Economic Impact of Ureteropelvic Junction Obstruction
38. 91: Comparison Between Open and Laparoscopic Nephron Sparing Surgery. Results From a Multicenter Experience
39. 51: Morbidity and Clinical Outome of Nephron Sparing Surgery in Relation to Tumor Size and Indication
40. 1774: Nephron-Sparing Surgery as the New Gold Standard for T1 ≤ 7 CM) Renal Cell Carcinoma: Results of a Contemporary Ucla Series
41. 1750: Prognostic Impact of Chromosomal Alterations in Renal cell Carcinoma Following Surgical Resection
42. 780: Carbonic Anhydrase IX (CAIX) Expression and VHL Gene Alteration as Predictors of Survival in Renal Cell Carcinoma
43. 779: RENCA/CAIX: A Murine Model of Renal Cell Carcinoma Expressing Carbonic Anhydrase IX
44. 782: Identification of T Cell Clones that Recognize Shared Renal Cell Carcinoma Antigens
45. The sensitivity of testosterone immunoassays and their role in monitoring antiandrogen therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.